Search results

Evidence-based recommendations on deep brain stimulation for refractory epilepsy in adults. This involves implanting an electrical stimulator in the brain.

Result type

Interventional procedures guidance

Published

12 August 2020

Evidence-based recommendations on MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy in adults and children. This involves inserting a laser into the area of the brain causing seizures.

Result type

Interventional procedures guidance

Published

4 March 2020

Evidence-based recommendations on vagus nerve stimulation for refractory epilepsy in children. This involves placing a device under the skin to send a burst of nerve messages through the nerve.

Result type

Interventional procedures guidance

Published

24 March 2004

This guideline covers diagnosing, assessing and managing cerebral palsy in children and young people from birth up to their 25th birthday. It aims to make sure they get the care and treatment they need for the developmental and clinical comorbidities associated with cerebral palsy, so that they can be as active and independent as possible.

Result type

NICE guideline

Published

25 January 2017

CG137/2 Question Epilepsy syndromes: What are the initial and add-on AEDs of choice in the treatment of the epilepsy...

Result type

Research recommendation

Published

13 August 2021

all-cause epilepsy-related death: Development of a risk prediction tool to detect all-cause mortality including sudden unexpected death...

Result type

Research recommendation

Published

11 May 2022

Evidence-based recommendations on cannabidiol (Epidyolex) for treating seizures caused by tuberous sclerosis complex.

Result type

Technology appraisal guidance

Published

1 March 2023

In development Reference number: GID-NG10453 Expected publication date: TBC

Result type

NICE guideline

Status

In development

Question Complex epilepsy syndromes: What antiseizure therapies (alternative or add-on) are effective in the treatment of complex...

Result type

Research recommendation

Published

11 May 2022

Evidence-based recommendations on fenfluramine (Fintepla) for treating seizures associated with Dravet syndrome in people aged 2 and older.

Result type

Technology appraisal guidance

Published

8 July 2022

This guideline covers children and young people with autism spectrum disorder (across the full range of intellectual ability) from birth until their 19th birthday. It covers the different ways that health and social care professionals can provide support, treatment and help for children and young people with autism, and their families and carers, from the early years through to their transition into young adult life.

Result type

Clinical guideline

Last updated

14 June 2021

Evidence-based recommendations on cannabidiol (Epidyolex) with clobazam for seizures associated with Dravet syndrome in people aged 2 years and older.

Result type

Technology appraisal guidance

Published

18 December 2019

Topic prioritisation

Result type

Medical technologies guidance

Status

Topic prioritisation

This indicator covers the percentage of patients with moderate or severe frailty and/or multimorbidity who have received a medication review in the last 12 months which is structured, has considered the use of a recognised tool and taken place as a shared discussion. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM186

Result type

General practice indicators suitable for use in QOF

Published

31 July 2019

effectiveness of providing tailored psychological treatments for people with epilepsy? Any explanatory notes(if applicable) For a short...

Result type

Research recommendation

Published

11 May 2022